查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654397

綜合症多重診斷市場規模、佔有率、趨勢分析報告（按類型、最終用途、地區、細分預測），2025 年至 2030 年

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

綜合多重診斷市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球症候群多重診斷市場規模預計到 2030 年將達到 36.6 億美元，2025 年至 2030 年期間的複合年成長率為 3.91%。市場的成長歸因於診斷技術的進步、各種疾病盛行率的上升、對快速準確診斷解決方案的需求不斷增加以及全球人口老化等因素。

傳統的診斷測試需要多個步驟並且通常需要很長時間才能產生結果，而綜合多重診斷則透過在一個樣本中同時測試多種病原體提供了全面的解決方案。此功能大大減少了診斷所需的時間，增加了各種需要快速診斷的醫療環境的需求。此外，呼吸系統疾病和胃腸道疾病等需要有效診斷解決方案的各種疾病的高發性也促進了市場的成長。例如，根據美國疾病管制與預防中心 (CDC) 的數據，2023 年美國診斷和記錄的梅毒、淋病和披衣菌感染病例超過 240 萬例。總合包括超過 209,000 例梅毒病例、超過 60 萬例淋病病例和超過 160 萬例披衣菌感染病例。預計此類感染疾病的高盛行率將在預測期內推動市場成長。

此外，市場參與企業不斷增加的研究和開發力度也推動了新的診斷解決方案的開發，並增加了最終用戶可獲得的多種診斷產品。例如，2021年1月，新加坡推出了由MiRXES開發的名為「Fortitude SARS-CoV-2 & Flu A/B Test」的多重診斷套件。此測試可檢測並區分 SARS-CoV-2 和甲型/乙型流感，從而提供更準確的診斷。該套件已獲得新加坡衛生科學局（HSA）的臨時批准。預計開發此類可提供更好結果的有效解決方案將增加這些解決方案的採用，從而推動市場成長。

對就地檢驗(POCT) 的需求不斷成長也促進了市場的成長。隨著對快速診斷的需求不斷增加，特別是在偏遠和服務不足的地區，多重診斷系統透過在單次測試中同時檢測多種病原體和疾病而提供了顯著的優勢。此外，亞洲、拉丁美洲、中東和非洲等地區正致力於改善其醫療保健基礎設施，促進採用能夠提供更快、更準確結果的綜合診斷系統。

綜合多重診斷市場報告重點

  • 按類型分類，呼吸系統疾病將在 2024 年佔據最大的市場佔有率。這是由於各種呼吸道感染疾病的發生率不斷增加以及有效診斷技術的日益普及。
  • 根據最終用途，診斷實驗室部門在 2024 年佔據最大的市場佔有率。這是因為這些設施的患者流動率高且可及性強。
  • 根據地區分類，北美將佔據市場主導地位，到 2024 年將佔 41.85% 的佔有率。由於主要市場參與企業的存在、不斷變化的監管環境、不斷改善的醫療保健基礎設施以及各種感染疾病的流行日益加劇，北美症候群多重診斷行業正在經歷顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 綜合多重診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 綜合多重診斷市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章 綜合多重診斷市場類型、估計與趨勢分析

  • 細分儀表板
  • 症候群多重診斷市場：類型變異分析
  • 2018 年至 2030 年綜合多重診斷市場規模及趨勢分析（按類型）
  • 呼吸系統
  • 胃腸道
  • 中樞神經系統
  • 其他類型的症候群（cUTI 和 STD）

第 5 章 綜合多重診斷市場：依最終用途的估計與趨勢分析

  • 細分儀表板
  • 綜合多重診斷市場：最終用途變異分析
  • 2018 年至 2030 年綜合多重診斷市場規模及趨勢分析（依最終用途）
  • 醫院
  • 診斷實驗室
  • 其他

第6章 綜合多重診斷市場：按地區分類的估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 2023 年主要企業的市場佔有率分析
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd
    • Qiagen
    • bioMerieux
    • DiaSorin SpA（Luminex Corporation）
    • Hologic, Inc.
    • Becton, Dickinson and Company（BD）
    • Applied BioCode
    • QIAGEN
    • Curetis GmbH
Product Code: GVR-4-68040-507-5

Syndromic Multiplex Diagnostics Market Growth & Trends:

The global syndromic multiplex diagnostics market size is anticipated to reach USD 3.66 billion by 2030, and it is expected to expand at a CAGR of 3.91% from 2025 - 2030, according to a new report by Grand View Research, Inc. The market's growth is attributed to factors such as technological advancements in diagnostics technologies, rising prevalence various diseases, growing demand for rapid and accurate diagnostics solutions, and global aging population.

Traditional diagnostic tests often require multiple steps and take longer to deliver results, whereas syndromic multiplex diagnostics offer a comprehensive solution by testing for multiple pathogens simultaneously in a single sample. This capability significantly reduces the time for diagnosis, increasing their demand in various healthcare settings where rapid diagnostics are preferred. Moreover, the high prevalence of various conditions, such as respiratory diseases, gastrointestinal conditions, and others, requiring effective diagnostics solutions further contributes to the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2023, more than 2.4 million instances of syphilis, gonorrhea, and chlamydia were diagnosed and documented in the U.S. This total includes over 209,000 syphilis cases, over 600,000 gonorrhea cases, and more than 1.6 million chlamydia cases. This high prevalence of infectious diseases is expected to fuel the market growth over the forecast period.

Moreover, the increasing R&D efforts by market players are leading to the development of new diagnostics solutions, increasing the availability of multiple diagnostics products for the end users. For instance, in January 2021, Singapore launched the Fortitude SARS-CoV-2 & Flu A/B Test, a multiplex diagnostic kit developed by MiRXES. This test detects and differentiates SARS-CoV-2 and influenza A/B, providing more accurate diagnoses. The kit received Provisional Authorisation from Singapore's Health Sciences Authority (HSA). The development of such effective solutions offering better results is expected to increase the adoption of these solutions and drive market growth.

The growing demand for Point-of-Care Testing (POCT) also contributes to market growth. With the rise in the demand for rapid diagnosis, especially in remote or underserved regions, multiplex diagnostic systems offer significant advantages by allowing for the simultaneous detection of multiple pathogens or diseases with a single test. Additionally, focuses on improving the healthcare infrastructure in regions such as Asia, Latin America and MEA are encouraging the implementation of integrated diagnostic systems that can provide faster and more accurate results.

Syndromic Multiplex Diagnostics Market Report Highlights:

  • Based on type, the bipolar respiratory segment held the largest market share in 2024. This is attributed to the rising prevalence of various respiratory infections and rising availability of effective diagnostics technologies.
  • Based on end use, the diagnostics laboratories segment held the largest market share in 2024. This is attributed to the high patient footfall in these facilities and their better accessibility to patients.
  • Based on region, North America dominated the market and accounted for a 41.85% share in 2024. The syndromic multiplex diagnostics industry in North America is experiencing significant growth driven by the presence of key market players, evolving regulatory landscape, developed healthcare infrastructure, and increasing prevalence of various infectious diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Syndromic Multiplex Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of infectious diseases
      • 3.2.1.2. Advancements in diagnostics technologies
      • 3.2.1.3. Growing demand for effective diagnostics solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of syndromic diagnostics solutions
  • 3.3. Syndromic Multiplex Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Syndromic Multiplex Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Syndromic Multiplex Diagnostics Market: Type Movement Analysis
  • 4.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Respiratory
    • 4.4.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Gastrointestinal
    • 4.5.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Central Nervous System
    • 4.6.1. Central Nervous System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Types of Syndromes (cUTI and STDs)
    • 4.7.1. Other Types of Syndromes (cUTI and STDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Syndromic Multiplex Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Syndromic Multiplex Diagnostics Market: End Use Movement Analysis
  • 5.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Laboratories
    • 5.5.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Syndromic Multiplex Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/Reimbursement
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/Reimbursement
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/Reimbursement
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/Reimbursement
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/Reimbursement
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/Reimbursement
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/Reimbursement
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/Reimbursement
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/Reimbursement
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/Reimbursement
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/Reimbursement
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/Reimbursement
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/Reimbursement
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/Reimbursement
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/Reimbursement
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/Reimbursement
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/Reimbursement
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/Reimbursement
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/Reimbursement
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/Reimbursement
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/Reimbursement
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/Reimbursement
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott Laboratories
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Services benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Thermo Fisher Scientific, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Services benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. F. Hoffmann-La Roche Ltd
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Services benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Qiagen
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Services benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. bioMerieux
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Services benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. DiaSorin S.p.A (Luminex Corporation)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Services benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Hologic, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Services benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Becton, Dickinson and Company (BD)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Services benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Applied BioCode
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Services benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. QIAGEN
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Services benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Curetis GmbH
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Services benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Mexico syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 Germany syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 UK syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 France syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Italy syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Spain syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Denmark syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Sweden syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Norway syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 Japan syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 India syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 Australia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 46 Latin America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 Brazil syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 50 Argentina syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 MEA syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Africa syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 59 UAE syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Syndromic multiplex diagnostics market: market outlook
  • Fig. 14 Syndromic multiplex diagnostics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Syndromic multiplex diagnostics market driver impact
  • Fig. 20 Syndromic multiplex diagnostics market restraint impact
  • Fig. 21 Syndromic multiplex diagnostics market strategic initiatives analysis
  • Fig. 22 Syndromic multiplex diagnostics market: Type movement analysis
  • Fig. 23 Syndromic multiplex diagnostics market: Type outlook and key takeaways
  • Fig. 24 Respiratory market estimates and forecasts, 2018 - 2030
  • Fig. 25 Gastrointestinal market estimates and forecasts, 2018 - 2030
  • Fig. 26 Central nervous system market estimates and forecasts, 2018 - 2030
  • Fig. 27 Other types of syndromes (cUTI and STDs) market estimates and forecasts, 2018 - 2030
  • Fig. 28 Syndromic multiplex diagnostics market: End Use movement analysis
  • Fig. 29 Syndromic multiplex diagnostics market: End Use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global syndromic multiplex diagnostics market: Regional movement analysis
  • Fig. 34 Global syndromic multiplex diagnostics market: Regional outlook and key takeaways
  • Fig. 35 Global syndromic multiplex diagnostics market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America, by country
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 46 Canada country dynamics
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 48 Mexico country dynamics
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Europe
  • Fig. 51 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 52 UK country dynamics
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 56 France country dynamics
  • Fig. 57 France market estimates and forecasts, 2018 - 2030
  • Fig. 58 Italy country dynamics
  • Fig. 59 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 60 Spain country dynamics
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 64 Sweden country dynamics
  • Fig. 65 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 68 Asia Pacific
  • Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 70 China country dynamics
  • Fig. 71 China market estimates and forecasts, 2018 - 2030
  • Fig. 72 Japan country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 74 India country dynamics
  • Fig. 75 India market estimates and forecasts, 2018 - 2030
  • Fig. 76 Thailand country dynamics
  • Fig. 77 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 78 South Korea country dynamics
  • Fig. 79 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 80 Australia country dynamics
  • Fig. 81 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 82 Latin America
  • Fig. 83 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 84 Brazil country dynamics
  • Fig. 85 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 86 Argentina country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Africa country dynamics
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 92 Saudi Arabia country dynamics
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 94 UAE country dynamics
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 96 Kuwait country dynamics
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 98 Market share of key market players - Syndromic multiplex diagnostics market, 2023
  • Fig. 99 Company Categorization